Zobrazeno 1 - 10
of 33
pro vyhledávání: '"implant buprenorphine"'
Publikováno v:
Substance Abuse and Rehabilitation
Substance abuse and rehabilitation, vol 2, iss 1
Substance abuse and rehabilitation, vol 2, iss 1
Pharmacotherapies for opioid addiction under active development in the US include lofexidine (primarily for managing withdrawal symptoms) and Probuphine®, a distinctive mode of delivering buprenorphine for six months, thus relieving patients, clinic
Autor:
Maremmani, Icro1,2 (AUTHOR) icro.maremmani@med.unipi.it, Dematteis, Maurice3 (AUTHOR) maurice.dematteis@univ-grenoble-alpes.fr, Gorzelanczyk, Edward J.4,5,6 (AUTHOR) medsystem@medsystem.com.pl, Mugelli, Alessandro7 (AUTHOR) alessandro.mugelli@unifi.it, Walcher, Stephan8 (AUTHOR) kontact@moviemed.de, Torrens, Marta9 (AUTHOR) mtorrens@hospitaldelmar.cat
Publikováno v:
Journal of Clinical Medicine. Sep2023, Vol. 12 Issue 17, p5575. 19p.
Publikováno v:
Perspectives in Psychiatric Care. Oct2022, Vol. 58 Issue 4, p2059-2063. 5p.
Autor:
Walker, Robert1 (AUTHOR) jrwalk0@uky.edu, Logan, TK1 (AUTHOR), Chipley, Quintin T.2 (AUTHOR), Miller, Jaime1 (AUTHOR), Logan, T K3 (AUTHOR)
Publikováno v:
American Journal of Drug & Alcohol Abuse. 2018, Vol. 44 Issue 6, p595-603. 9p.
Publikováno v:
Journal of Oral Rehabilitation; Aug2022, Vol. 49 Issue 8, p796-805, 10p, 5 Color Photographs
Autor:
Soyka, Michael
Publikováno v:
Pharmacopsychiatry; 2021, Vol. 54 Issue 1, p18-22, 5p
Autor:
O'Connor, Patrick G.
Publikováno v:
JAMA: Journal of the American Medical Association; 10/13/2010, Vol. 304 Issue 14, p1612-1614, 3p
Publikováno v:
Cerebral Cortex; Sep2020, Vol. 30 Issue 9, p5121-5146, 26p
Autor:
Patnode, Carrie D., Perdue, Leslie A., Rushkin, Megan, Dana, Tracy, Blazina, Ian, Bougatsos, Christina, Grusing, Sara, O'Connor, Elizabeth A., Fu, Rongwei, Chou, Roger
Publikováno v:
JAMA: Journal of the American Medical Association; 6/9/2020, Vol. 323 Issue 2, p2310-2328, 19p
Autor:
Cosgrove, James cosgrovej@gao.gov
Publikováno v:
GAO Reports. 8/4/2020, preceding pi-16. 20p.